PNPLA3 and Insulin resistance: The PNPLA3 genotype interacts with both nonmodifiable (age, sex, genetic ancestry) and modifiable risk factors (visceral adiposity, obesity, insulin resistance, lipids) to multiplicatively increase risk of hepatic steatosis (66) (Figure 2).